SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Veracyte Q2 EPS $(0.22) Beats $(0.24) Estimate, Sales $20.70M Beat $20.60M Estimate

Veracyte (NASDAQ:VCYT) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 8.33 percent. This is a 340 percent decrease over losses of $(0.05) per share from the same

Benzinga · -
Veracyte (NASDAQ: VCYT) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 8.33 percent. This is a 340 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $20.70 million which beat the analyst consensus estimate of $20.60 million by 0.49 percent. This is a 31.31 percent decrease over sales of $30.14 million the same period last year.